Background – Hyperacidity is one of the most common diseases seen in all ages. Hyperacidity simply means an
increased level of acid in the stomach. Unani system of medicine has a treasure of formulations for the treatment of
hyperacidity.
Methods- Present open labeled,multi-centric, single arm validation was conducted to evaluate the safety and efficacy
of Unani pharmacopeial drug Jawarish Amla and Habb-e-Papita in Humuzat-e-Meda (Hyperacidity). Patients with
symptoms of hyperacidity like retro-sternal burning,epigastric pain with retro-sternal heaviness,acidic brash,anorexia,
nausea and vomiting were included. Patients with known duodenal ulcers, peptic ulcer, gastric surgery gastric
carcinoma, Crohn's Diseases, Zollinger Ellison Syndrome, cardiac disorders, respiratory ailments, Diabetes Mellitus,
pregnant and lactating females were excluded. Unani formulations,Jawarish Amla 10 g and Habb e Papita 2 tablets were
given twice daily after meals for 6 weeks. Clinical & haematological parameters were assessed before and after the
treatment to evaluate the safety and efficacy of the drug.
Results– No significant changes are observed after 28 days and 84 days during the therapy in the safety profiles of
laboratory investigations such as complete haemogram, LFT, KFT. There is significant improvement in the sign and
symptoms associated withHumuzat-e-Meda (Hyperacidity).
Conclusion- Unani compound formulations Jawarish Amla and Habb-e-Papita are safe and effective in the management
ofHumuzat-e-Meda (Hyperacidity).